List of Next-Gen Sequencing Companies in Maryland - 12

CosmosID provides award-winning, end-to-end microbiome solutions. They offer NGS, Metabolomics, Bioinformatics, as well as the world's most advanced microbiome analysis software, CosmosID-HUB: Microbiome. The HUB relies on validated databases and algorithms specifically designed for maximum sensitivity, precision and lowest false positive rates. Unlike other solutions, CosmosID delivers strain-level results – we understand that the biologically informative and actionable unit in microbiology is not a genus or species, but ultimately a strain and its unique genetic and metabolic properties. CosmosID was founded in 2008 by Dr. Rita Colwell, former director of the National Science Foundation and currently Distinguished University Professor at the University of Maryland and Johns Hopkins University Bloomberg School of Public Health. To learn more please visit www.cosmosid.com.

DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.

DNA Technologies presents a unique anti-counterfeiting and brand protection solution to the marketplace through its combination of synthetic, DNA-laced security markers. We are dedicated to helping manufacturers, authenticators, license & trademark holders, governments and publishers worldwide eliminate the production and distribution of counterfeit goods. DNA Technologies uses expert knowledge to construct unique, synthetic DNA sequences that can encode company and product-specific information into inks, dyes and resins, to provide the ultimate security marker – the DNA MatrixTM. DNA Technologies has become the recognized leader in providing security marking and unequalled protection for valuable products, brands and intellectual property. This patented and proprietary technology has been used to protect the products and brands of Thomas Kinkade, Major League Baseball, the National Hockey League, the Super Bowl, Hanna-Barbera, BRL Hardy's Wines and the 2000 Sydney Olympics.

EdgeBio has a team of experienced research professionals that are knowledgeable in next generation sequencing technologies and applications. From library preparation through data analysis, EdgeBio representatives are there to discuss your project on a custom basis to ensure that you receive the results you need for your research. Follow us on Twitter at: https://twitter.com/EdgeBio

SeraCare, part of LGC's Clinical Diagnostics Division, enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Our innovative tools and technologies not only ensure the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics. Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents.

At Magbio Genomics, we are dedicated to advancing genetic research with cutting-edge products designed to safeguard the integrity of bio-samples while efficiently isolating circulating biomarkers. Specializing in human genetic research, including cancer studies and non-invasive prenatal testing (NIPT), our innovative solutions empower researchers to unlock invaluable insights. At the heart of our operations lies our core platform, enabling seamless nucleic acid sequencing methods such as Sanger and Next Generation Sequencing (NGS) across both manual and automated workflows. Our commitment extends beyond product development; it's about facilitating quality data generation at an accelerated pace and an accessible cost. Driven by our corporate mission, we strive to empower our customers to achieve their research goals efficiently and effectively, propelling scientific discoveries forward with Magbio Genomics by their side.

Protein BioSolutions provides viable solutions for scientists involved in DNA sequencing and in protein production, purification, characterization and crystallography.

Psomagen, Inc., formerly Macrogen Corp, delivers genomic sequencing services to the clinical, academic, and consumer markets. Psomagen's labs are US-based and CLIA and CAP certified. Not only is the company accredited to perform the highest quality Sanger sequencing, Next-Generation Sequencing and Microarray Gene Analysis, it is also networked with Macrogen's worldwide headquarters, stretching its capabilities and capacity across a diverse set of labs around the world. Learn more at psomagen.com.

SeraCare, part of LGC's Clinical Diagnostics Division, enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Our innovative tools and technologies not only ensure the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics. Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents.

Speed BioSystems is a biomedical research reagents company that offers high-quality products with speedy delivery services.

TrimGen is a precision medicine company that specializes in pharmacogenomics for behavioral health and chronic pain.

xMD Diagnostics, Inc. is a molecular diagnostics tools company focused on developing a line of laboratory instruments and consumables for the rapidly growing research, biopharmaceutical and commercial clinical laboratory (CLIA) precision diagnostics markets. xMD's goal is to significantly improve pathologists', oncologists' and other physicians' ability to diagnose, monitor and treat patients with cancer and other serious genetic diseases.